Peijia Medical, a China-based domestic medical device company focused on transcatheter valve therapeutics and neurovascular inter ...

March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...

Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating the safety and eff ...

Imperative Care, Inc., a developer of treatments for thromboembolic disease, announced the closing of a $100 million convertible ...

Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of pulmona ...

Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...

Boston Scientific announced FDA clearance for the “Any Day Dosing” feature on the company’s TheraSphere 360 ytt ...

Cook Medical announced it has selected Indiana University (IU) in Indianapolis, Indiana, as one of the first Interventional MRI ( ...

Three-year outcomes from the PERFORMANCE II trial studying the Neuroguard Integrated Embolic Protection (IEP) 3-in-1 Carotid Sten ...

IceCure Medical Ltd. announced that the FDA has approved the study design for the ChoICE trial, the company’s postmarketing ...

VS3 Medical, Inc. announced it has commenced enrollment in an international first-in-human (FIH) study evaluating the VS3 Med ...